{"id":"W2756174617","doi":"10.1111/dom.13114","title":"Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The <scp>ODYSSEY DM‐INSULIN</scp> randomized trial","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Internal medicine; Type 2 diabetes; Endocrinology; Placebo; Type 1 diabetes; Cholesterol; Insulin; Diabetes mellitus; PCSK9; Population; Apolipoprotein B; Lipoprotein; Apolipoprotein A1; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001836609,0.0004107977,0.001976135,0.0002002515,0.00037719,0.0001510564,0.0002024847,0.0001807593,0.00001136125],"category_scores_gemma":[0.00190476,0.000229381,0.0001642123,0.0002540153,0.0006729702,0.0002269929,0.000262597,0.0002604557,0.000003570802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001508331,"about_ca_system_score_gemma":0.00005728261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002720076,"about_ca_topic_score_gemma":0.00003006174,"domain_scores_codex":[0.9976918,0.0004113097,0.0004889267,0.0005327598,0.0003961505,0.0004790699],"domain_scores_gemma":[0.9975565,0.0009025131,0.0003846364,0.000816306,0.0001510858,0.0001889703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09400989,0.001647017,0.8140193,0.0007088202,0.01694908,0.00004290578,0.002430718,0.00002461643,0.000232108,0.001023199,0.0002637467,0.06864861],"study_design_scores_gemma":[0.3932543,0.0004615663,0.5947263,0.0001673285,0.004884203,7.55301e-7,0.00005745972,0.00004859333,0.0008965408,0.0002074414,0.005183242,0.0001122307],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9690209,0.02739519,0.000002421386,0.0001081843,0.0002157236,0.002832468,0.00004416324,0.00004061855,0.0003402994],"genre_scores_gemma":[0.9786322,0.02030698,0.0003609981,0.0001039974,0.0001503947,0.00008933132,0.00007010139,0.00003555019,0.0002505008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2992444,"threshold_uncertainty_score":0.9353887,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01075347439363494,"score_gpt":0.2304660606959438,"score_spread":0.2197125863023089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}